Crestline Investors, Inc., 10% Owner at Denali Therapeutics Inc. (DNLI), sold 3,845,710 shares at $25.75 ($99.0M) on 2020-06-05, disclosed to the SEC on 2020-06-09.
Open-market sale of $99.0M DNLI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.75 | 1,922,855 | $49.5M | 50.0% |
| 2 | $25.75 | 1,922,855 | $49.5M | 50.0% |
| Total | $25.75 avg | 3,845,710 | $99.0M | 100% |
| Filing → |
| JUNO | SELL | 2016-03-03 | $335.4M | — | Filing → |